Insider Actions for Denali Therapeutics Inc.
01/09/2023 |
Carole Ho Chief Medical Officer |
1,459 | Disposition at $28.48 per share. | 41,552 |
01/06/2023 |
Carole Ho Chief Medical Officer |
1,451 | Disposition at $28.67 per share. | 41,600 |
01/05/2023 |
Ryan J. Watts President and CEO; Director |
4,800 | Disposition at $28.44 per share. | 136,512 |
01/05/2023 |
Steve E. Krognes Director |
2,970 | Disposition at $28.44 per share. | 84,466 |
01/05/2023 |
Alexander O. Schuth COFO and Secretary |
2,636 | Disposition at $28.44 per share. | 74,967 |
01/05/2023 |
Carole Ho Chief Medical Officer |
2,636 | Disposition at $28.44 per share. | 74,967 |
01/04/2023 |
Ryan J. Watts President and CEO; Director |
5,029 | Disposition at $28.73 per share. | 144,483 |
01/04/2023 |
Alexander O. Schuth COFO and Secretary |
2,912 | Disposition at $28.7 per share. | 83,574 |
01/04/2023 |
Alexander O. Schuth COFO and Secretary |
2,912 | Disposition at $28.7 per share. | 83,574 |
01/04/2023 |
Carole Ho Chief Medical Officer |
2,913 | Disposition at $28.69 per share. | 83,573 |
01/03/2023 |
Ryan J. Watts President and CEO; Director |
82,240 | Award at $0 per share. | 0 |
01/03/2023 |
Alexander O. Schuth COFO and Secretary |
41,120 | Award at $0 per share. | 0 |
01/03/2023 |
Carole Ho Chief Medical Officer |
41,120 | Award at $0 per share. | 0 |
11/23/2022 |
Marc Tessier-Lavigne Director |
20,000 | Disposition at $30.48 per share. | 609,600 |
11/02/2022 |
Marc Tessier-Lavigne Director |
11,252 | Disposition at $30.33 per share. | 341,273 |
11/01/2022 |
Marc Tessier-Lavigne Director |
8,748 | Disposition at $30.2 per share. | 264,189 |
10/07/2022 |
Alexander O. Schuth COFO and Secretary |
20,000 | Derivative/Non-derivative trans. at $0.68 per share. | 13,600 |
09/28/2022 |
Marc Tessier-Lavigne Director |
4,423 | Disposition at $31.08 per share. | 137,466 |
09/28/2022 |
Marc Tessier-Lavigne Director |
15,577 | Disposition at $30.74 per share. | 478,836 |